Detection of single clone deletions using array CGH

Identification of submicroscopic deletions in the 22q11.2 deletion syndrome as a model system

Taku A. Tokuyasu, Philip D. Cotter, Richard Segraves, Jeffrey Harris, Melissa E. Elder, Marcos Gonzales, Daniel Pinkel, Donna Albertson, Katherine A. Rauen

Research output: Contribution to journalArticle

Abstract

Constitutional submicroscopic DNA copy number alterations have been shown to cause numerous medical genetic syndromes, and are suspected to occur in a portion of cases for which the causal events remain undiscovered. Array comparative genomic hybridization (array CGH) allows high-throughput, high-resolution genome scanning for DNA dosage aberrations and thus offers an attractive approach for both clinical diagnosis and discovery efforts. Here we assess this capability by applying array CGH to the analysis of copy number alterations in 44 patients with a phenotype of the 22q11.2 deletion syndrome. Twenty-five patients had the deletion on chromosome 22 characteristic of this syndrome as determined by fluorescence in situ hybridization (FISH). The array measurements were in complete concordance with the FISH analysis, supporting their diagnostic utility. These data show that a genome-scanning microarray has the level of sensitivity and specificity required to prospectively interrogate and identify single copy number aberrations in a clinical setting. We demonstrate that such technology is ideally suited for microdeletion syndromes such as 22q11.2.

Original languageEnglish (US)
Pages (from-to)925-932
Number of pages8
JournalAmerican Journal of Medical Genetics, Part A
Volume143
Issue number9
DOIs
StatePublished - May 1 2007

Fingerprint

DiGeorge Syndrome
Comparative Genomic Hybridization
Clone Cells
Fluorescence In Situ Hybridization
Genome
Chromosomes, Human, Pair 22
DNA
Medical Genetics
Technology
Phenotype
Sensitivity and Specificity

Keywords

  • 22q11.2 deletion syndrome
  • Array CGH
  • Array comparative genomic hybridization
  • Chromosome 22q
  • Genome-wide scan
  • Polymorphism
  • Submicroscopic deletion syndrome

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Detection of single clone deletions using array CGH : Identification of submicroscopic deletions in the 22q11.2 deletion syndrome as a model system. / Tokuyasu, Taku A.; Cotter, Philip D.; Segraves, Richard; Harris, Jeffrey; Elder, Melissa E.; Gonzales, Marcos; Pinkel, Daniel; Albertson, Donna; Rauen, Katherine A.

In: American Journal of Medical Genetics, Part A, Vol. 143, No. 9, 01.05.2007, p. 925-932.

Research output: Contribution to journalArticle

Tokuyasu, Taku A. ; Cotter, Philip D. ; Segraves, Richard ; Harris, Jeffrey ; Elder, Melissa E. ; Gonzales, Marcos ; Pinkel, Daniel ; Albertson, Donna ; Rauen, Katherine A. / Detection of single clone deletions using array CGH : Identification of submicroscopic deletions in the 22q11.2 deletion syndrome as a model system. In: American Journal of Medical Genetics, Part A. 2007 ; Vol. 143, No. 9. pp. 925-932.
@article{ca2d0e5f993645dd87bc355592089b41,
title = "Detection of single clone deletions using array CGH: Identification of submicroscopic deletions in the 22q11.2 deletion syndrome as a model system",
abstract = "Constitutional submicroscopic DNA copy number alterations have been shown to cause numerous medical genetic syndromes, and are suspected to occur in a portion of cases for which the causal events remain undiscovered. Array comparative genomic hybridization (array CGH) allows high-throughput, high-resolution genome scanning for DNA dosage aberrations and thus offers an attractive approach for both clinical diagnosis and discovery efforts. Here we assess this capability by applying array CGH to the analysis of copy number alterations in 44 patients with a phenotype of the 22q11.2 deletion syndrome. Twenty-five patients had the deletion on chromosome 22 characteristic of this syndrome as determined by fluorescence in situ hybridization (FISH). The array measurements were in complete concordance with the FISH analysis, supporting their diagnostic utility. These data show that a genome-scanning microarray has the level of sensitivity and specificity required to prospectively interrogate and identify single copy number aberrations in a clinical setting. We demonstrate that such technology is ideally suited for microdeletion syndromes such as 22q11.2.",
keywords = "22q11.2 deletion syndrome, Array CGH, Array comparative genomic hybridization, Chromosome 22q, Genome-wide scan, Polymorphism, Submicroscopic deletion syndrome",
author = "Tokuyasu, {Taku A.} and Cotter, {Philip D.} and Richard Segraves and Jeffrey Harris and Elder, {Melissa E.} and Marcos Gonzales and Daniel Pinkel and Donna Albertson and Rauen, {Katherine A.}",
year = "2007",
month = "5",
day = "1",
doi = "10.1002/ajmg.a.31662",
language = "English (US)",
volume = "143",
pages = "925--932",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Detection of single clone deletions using array CGH

T2 - Identification of submicroscopic deletions in the 22q11.2 deletion syndrome as a model system

AU - Tokuyasu, Taku A.

AU - Cotter, Philip D.

AU - Segraves, Richard

AU - Harris, Jeffrey

AU - Elder, Melissa E.

AU - Gonzales, Marcos

AU - Pinkel, Daniel

AU - Albertson, Donna

AU - Rauen, Katherine A.

PY - 2007/5/1

Y1 - 2007/5/1

N2 - Constitutional submicroscopic DNA copy number alterations have been shown to cause numerous medical genetic syndromes, and are suspected to occur in a portion of cases for which the causal events remain undiscovered. Array comparative genomic hybridization (array CGH) allows high-throughput, high-resolution genome scanning for DNA dosage aberrations and thus offers an attractive approach for both clinical diagnosis and discovery efforts. Here we assess this capability by applying array CGH to the analysis of copy number alterations in 44 patients with a phenotype of the 22q11.2 deletion syndrome. Twenty-five patients had the deletion on chromosome 22 characteristic of this syndrome as determined by fluorescence in situ hybridization (FISH). The array measurements were in complete concordance with the FISH analysis, supporting their diagnostic utility. These data show that a genome-scanning microarray has the level of sensitivity and specificity required to prospectively interrogate and identify single copy number aberrations in a clinical setting. We demonstrate that such technology is ideally suited for microdeletion syndromes such as 22q11.2.

AB - Constitutional submicroscopic DNA copy number alterations have been shown to cause numerous medical genetic syndromes, and are suspected to occur in a portion of cases for which the causal events remain undiscovered. Array comparative genomic hybridization (array CGH) allows high-throughput, high-resolution genome scanning for DNA dosage aberrations and thus offers an attractive approach for both clinical diagnosis and discovery efforts. Here we assess this capability by applying array CGH to the analysis of copy number alterations in 44 patients with a phenotype of the 22q11.2 deletion syndrome. Twenty-five patients had the deletion on chromosome 22 characteristic of this syndrome as determined by fluorescence in situ hybridization (FISH). The array measurements were in complete concordance with the FISH analysis, supporting their diagnostic utility. These data show that a genome-scanning microarray has the level of sensitivity and specificity required to prospectively interrogate and identify single copy number aberrations in a clinical setting. We demonstrate that such technology is ideally suited for microdeletion syndromes such as 22q11.2.

KW - 22q11.2 deletion syndrome

KW - Array CGH

KW - Array comparative genomic hybridization

KW - Chromosome 22q

KW - Genome-wide scan

KW - Polymorphism

KW - Submicroscopic deletion syndrome

UR - http://www.scopus.com/inward/record.url?scp=34247892309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247892309&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.31662

DO - 10.1002/ajmg.a.31662

M3 - Article

VL - 143

SP - 925

EP - 932

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 9

ER -